News

6 Sep 2013

Likvor was one of the exhibitors at the early Hydrocephalus 2013 conference in Athens.

Demonstrated the CELDA System and informed about upcoming news for existing and new contacts.

Looking forward to see you soon again at the next conference. Meanwhile please contact us for any further information or documentation.

 

14 Mar 2013

Likvor will be present at the yearly ISHCSF meeting which will take place in Athens , June 29 - July 2, 2013.

Hydrocephalus 2013 Athens, is the Fifth Meeting of the International Society of Hydrocephalus and CSF Disorders.

Please come and visit us at our booth.

14 Mar 2013

Likvor is proud to present our coming Likvor CELDA User Meeting in Stockholm at Park Hotel. For more information please contact:

mats.hogberg (@) likvor.com

Date:  April, 25-26, 2013 in Stockholm

14 Mar 2013

Likvor will be present at the Berlin Neurosurgical Meeting (Berliner Neurochirurgentag) 19th April 2013.

On site it will be possible to se our demo of the Likvor CELDA® System.

 

19 Dec 2012

Likvor Ltd, a medical device company in Umeå, has further strengthened its presence outside of Sweden by selling Likvor CELDA® System to Rigshospitalet in Copenhagen. The system is used to better diagnose patients with treatable dementia, NPH, and has attracted much attention.

26 Nov 2012

Umeå-based medical technology company Likvor is working intensively with the international launch of the patented Likvor CELDA® System and got a prestigious order from the Netherlands. The system can provide millions of dementia patients back to life, and has attracted much attention.

16 Aug 2012

Likvor has increased the staff with two new employees. Now they are six in total.

16 May 2012

2012 meeting of the International Society of Hydrocephalus and CSF Disorders (ISHCSF), will be held in Kyoto from October 19 to 22, 2012 (Hydrocephalus 2012, Kyoto). http://www.ishcsf2012.jp/index.html

13 Apr 2012

An ownership group consisting of Uminova Invest, PartnerInvest and former CEO Kjell Öberg acquires Allenex' holdings in Likvor to strengthen the company's ownership structure. The medtech-company Likvor AB manufactures and sells the unique Likvor CELDA® System which can identify a way back to normalized life for millions of dementia patients with the condition NPH, also known as treatable dementia.

29 Nov 2011

The medtech company Likvor AB strengthens its competences with a new chairman of the board, Stefan Sallerfors. Sallerfors has a background as doctor and specialist in medical radiology and has been CEO for GE Medical System Sverige AB and Helsingborg hospital. In November Likvor continues the expansion on the European market with a new distribution agreement for the German market. The unique Likvor CELDA® System is therefore available in Germany, Austria and Switzerland through the new distributor, Neuromed. The system helps to restore normal life back to millions of dementia patients with hydrocephalus diagnosis.

Pages